NCT05135572

Brief Summary

Widespread pain is observed in patients diagnosed with fibromyalgia, and lower extremity and foot pain are also common. In our study, we aimed to evaluate the relationship between foot pain and tarsal tunnel syndrome in female patients diagnosed with fibromyalgia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 24, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 26, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

February 1, 2022

Completed
27 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2022

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
Last Updated

June 1, 2022

Status Verified

November 1, 2021

Enrollment Period

27 days

First QC Date

November 24, 2021

Last Update Submit

May 30, 2022

Conditions

Keywords

Tarsal Tunnel Syndrome, Fibromyalgia, Neuropathic pain, EMG

Outcome Measures

Primary Outcomes (3)

  • Electrodiagnostic studies

    It is a neurological examination method based on the examination of the electrical potential of nerves and striated muscles.

    15 minutes

  • Fibromyalgia Impact Questionnaire (FIQ)

    This scale measures several patient characteristics over the past week: physical functioning, work status, depression, anxiety, morning tiredness, pain, stiffness, fatigue, and well-being.The total FIQ score ranges from 0 to 100 and higher scores indicate severe effects of FMS. The minimal clinical important difference (MCID) for FIQ was reported to be minimum 14% or 8.1-point improvement

    3 minutes

  • Neuropathic Pain Questionnaire.

    This scala measures the type of pain, whether it has changed over time, and whether the pain is in one or more regions.This scala measures the type of pain, whether it has changed over time, and whether the pain is in one or more regions. It consists of 12 questions. Each question is scored between 0 and 100 points. It is multiplied by the coefficients determined for each question. All the resulting values are summed up, including fixed numbers. The result of the sum reflects the discriminant function score. Individuals with a score below 0 are predicted to have non-neuropathic pain, while those with a score of 0 or higher are predicted to have neuropathic pain

    3 minutes

Study Arms (2)

control group

ACTIVE COMPARATOR

Fibromiyalgia patients with foot pain.

Diagnostic Test: Fibromiyalgia and foot pain

study group

EXPERIMENTAL

Patients with foot pain

Diagnostic Test: Fibromiyalgia and foot pain

Interventions

Sensory and motor conduction studies will be performed in the lower extremities. Nerve conduction studies will be performed by another physician unaware of the patient's diagnosisFunctional status will be evaluated by using the Turkish version of the Fibromyalgia Impact Questionnaire (FIQ).Neuropathic Pain will be evalutaed by using the Turkish version of the Neuropathic Pain Questionnaire.

Also known as: Patients with foot pain
control groupstudy group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age
  • Diagnosed with fibromyalgia according to ACR criteria

You may not qualify if:

  • Have any severe mental or psychological disorder
  • Have significant hearing and/or vision loss
  • Presence of foot deformity, previous fracture, arthritis, tendon pathology that may cause foot pain detected in the physical examination of the foot and ankle joint.
  • Presence of systemic inflammatory disease
  • Having any systemic disease that may cause polyneuropathy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kutahya Health Scıence University

Kütahya, Kütahya, 43000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Tarsal Tunnel SyndromeFibromyalgiaNeuralgia

Condition Hierarchy (Ancestors)

Tibial NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesMuscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 24, 2021

First Posted

November 26, 2021

Study Start

February 1, 2022

Primary Completion

February 28, 2022

Study Completion

March 1, 2022

Last Updated

June 1, 2022

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations